SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study

Journal of Affective Disorders
Gordon ParkerDusan Hadzi-Pavlovic

Abstract

We have previously observed that prescription of some antidepressant class drugs (particularly the SSRIs) is associated with attenuation of the number, duration and severity of both high and low mood states in those with Bipolar II Disorder. We examined whether SSRIs are a mood stabilizer for Bipolar II Disorder. We report a randomized, double-blind, placebo-controlled cross-over study lasting 9 months in a sample of 10 patients who had not had previous treatment with any antidepressant, antipsychotic or mood stabilizer drug. Treatment with the SSRI led to a significant reduction in depression severity, percentage of days depressed or high, and percentage of days impaired, when compared with placebo. There was no indication that the SSRI led to a worsening of illness course. Given the small sample size and a weighting to those with a rapid cycling condition, replication with a larger and more heterogeneous sample of those with Bipolar Disorder is required. This proof of concept study finds preliminary support for the potential utility of SSRIs in managing Bipolar II Disorder, with clear improvements in depression and impairment and some suggested benefit for hypomania.

References

Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
Apr 24, 2001·European Archives of Psychiatry and Clinical Neuroscience·F Benazzi
Jun 13, 2002·The Australian and New Zealand Journal of Psychiatry·Gordon Parker
Jul 23, 2003·Journal of Psychopharmacology·G M Goodwin, UNKNOWN Consensus Group of the British Association for Psychopharmacology
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Nov 26, 2003·Bipolar Disorders·Jay D Amsterdam, David J Brunswick
Sep 1, 2004·The American Journal of Psychiatry·Harm J GijsmanGuy M Goodwin

❮ Previous
Next ❯

Citations

Oct 29, 2011·European Archives of Psychiatry and Clinical Neuroscience·Thomas C BaghaiUNKNOWN Section of Pharmacopsychiatry, World Psychiatric Association
May 25, 2012·European Archives of Psychiatry and Clinical Neuroscience·Konstantinos N FountoulakisEduard Vieta
Oct 16, 2012·Current Psychiatry Reports·Michelle M Sidor, Glenda M MacQueen
Feb 9, 2013·CNS Spectrums·Laura MusettiLiliana Dell'Osso
Nov 11, 2009·Current Opinion in Psychiatry·Konstantinos N Fountoulakis
Mar 26, 2011·Annals of General Psychiatry·Konstantinos N FountoulakisZoltan Rihmer
Nov 14, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·Amir Shabani
Jun 20, 2014·Journal of Clinical Psychopharmacology·Rudy C BowenMarilyn Baetz
Oct 27, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Jay D AmsterdamJustine Shults
Jan 9, 2014·Expert Opinion on Emerging Drugs·Paul A Keedwell, Allan H Young
Feb 13, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force On Treatment Guidelines For Bipolar Disorders
Jan 25, 2016·Acta Psychiatrica Scandinavica·L Lorenzo-LuacesR J DeRubeis
Nov 26, 2010·Journal of Affective Disorders·Judith ProudfootGordon Parker
Feb 10, 2012·Depression Research and Treatment·Ben H Amit, Abraham Weizman
Oct 16, 2008·Acta Psychiatrica Scandinavica·Eduard Vieta
Apr 10, 2007·Journal of Clinical Psychology·Joseph F Goldberg
Feb 27, 2013·Bipolar Disorders·Konstantinos N FountoulakisLakshmi N Yatham
Feb 20, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Jay D AmsterdamRobert J DeRubeis
Mar 14, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
May 20, 2008·Journal of Affective Disorders·F ColomJ Scott
May 24, 2011·Journal of Affective Disorders·Konstantinos N FountoulakisHagop Akiskal
Apr 18, 2012·The Australian and New Zealand Journal of Psychiatry·S Nassir Ghaemi
Mar 31, 2009·Journal of Psychopharmacology·G M Goodwin, UNKNOWN Consensus Group of the British Association for Psychopharmacology
Jul 1, 2009·Expert Review of Clinical Pharmacology·Vivek Datta, Anthony J Cleare
Aug 1, 2019·Expert Opinion on Drug Safety·Elie Cheniaux, Antonio E Nardi
May 13, 2020·Frontiers in Psychiatry·Alessio SimonettiGabriele Sani
Nov 15, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Philip B Mitchell
Sep 7, 2006·CNS Drugs·Sohita DhillonGreg L Plosker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here